CDC73 and hypercalcemia disease: Mamoedova et al. [65] considered that controlling hypercalcemia via medical therapy allowed for a useful timeframe in which to obtain the results of the genetic analysis (in this case, it revealed a heterozygote status of the CDC73 gene).